In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
SABCS co-chair and AACR President Carlos L. Arteaga, MD, shares his views on this year's symposium and what the...
Guest Post by T.J. Sharpe Originally appeared on Philly.com's Patient #1 blog
Through think tanks, special conferences, and its Pediatric Cancer Working Group, the AACR is taking steps to establish childhood...
With the 2014 midterm elections behind us and the U.S. Congress in the midst of a “lame duck” session,...
Nina Bhardwaj, MD, PhD, co-chair of the AACR's special conference "Tumor Immunology and Immunotherapy: A New Chapter," discusses what...
Despite current screening efforts, colorectal cancer is the fourth most commonly diagnosed cancer worldwide and the fifth leading cause...
Costas Lyssiotis, PhD, a 2013 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant recipient, is conducting research to understand...
The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses...
Research has fueled significant progress against breast cancer—the overall five-year survival rate for female breast cancer patients in the...
In a Los Angeles Times op-ed, Cynthia Ryan, a two-time breast cancer survivor, past participant in the AACR Scientist↔Survivor...